MedTrace Logo

Effect of Oral Procaterol on Postinfectious Persistent Cough

NCT02349919 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2017-03-23

No results posted yet for this study

Summary

The purpose of this study is to investigate the effectiveness of oral procaterol in treatment of non-asthmatic patients who suffer from persistent cough following upper respiratory tract infection (URTI).

Conditions

Interventions

DRUG

Procaterol

Procaterol 25 micrograms/tablet, 1 tablet twice daily for 4 weeks

DRUG

Placebo

Placebo twice daily for 4 weeks

Sponsors & Collaborators

  • Thai Otsuka Pharmaceutical Co., Ltd.

    collaborator INDUSTRY

  • Mahidol University

    lead OTHER

Principal Investigators

  • Prapaporn Pornsuriyasak, M.D. · Pulmonary and Critical Care, Department of Medicine, Ramathibodi Hospital, Mahidol University

  • Theerasuk Kawamatawong, M.D. · Pulmonary and Critical Care, Department of Medicine, Ramathibodi Hospital, Mahidol University

  • Poungrat Thungtitigul, M.D. · Pulmonary and Critical Care, Department of Medicine, Ramathibodi Hospital, Mahidol University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2017-12-31
Completion
2018-01-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02349919 on ClinicalTrials.gov